Who are Botulinum Toxin-A injection's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Botulinum Toxin Type A 900kD, OnabotulinumtoxinA 100 UNT [Botox], Botox infiltration, Botulinum Toxin Type-A (day 0), Botulinum toxin A "Botox Cosmetics", botulinum type a.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/botulinum-toxin-a-injection.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Botulinum Toxin-A injection — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Botulinum Toxin-A injection (Botulinum Toxin-A injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neurotoxin; neuromuscular blocking agent. Area: Neurology; Orthopedics; Aesthetics.

marketed Neurotoxin; neuromuscular blocking agent SNARE complex (specifically cleaves SNAP-25) Neurology; Orthopedics; Aesthetics Small molecule Live · refreshed every 30 min

Target snapshot

Botulinum Toxin-A injection (Botulinum Toxin-A injection) — Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust. Botulinum toxin-A blocks the release of acetylcholine at the neuromuscular junction, causing temporary muscle paralysis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Botulinum Toxin-A injection TARGET	Botulinum Toxin-A injection	Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust	marketed	Neurotoxin; neuromuscular blocking agent	SNARE complex (specifically cleaves SNAP-25)
Botulinum Toxin Type A 900kD	Botulinum Toxin Type A 900kD	Allergan	marketed	Neurotoxin; acetylcholine release inhibitor	SNAP-25 (synaptosome-associated protein of 25 kDa)
OnabotulinumtoxinA 100 UNT [Botox]	OnabotulinumtoxinA 100 UNT [Botox]	Women and Infants Hospital of Rhode Island	marketed	Neurotoxin; botulinum toxin type A	SNAP-25 (synaptosome-associated protein of 25 kDa)
Botox infiltration	Botox infiltration	University Rovira i Virgili	marketed	Neurotoxin; botulinum toxin type A	SNARE complex (synaptosome-associated protein); acetylcholine release machinery
Botulinum Toxin Type-A (day 0)	Botulinum Toxin Type-A (day 0)	Ivo Pitanguy Institute	marketed	Neurotoxin; neuromuscular blocking agent	SNAP-25 (synaptosome-associated protein of 25 kDa)
Botulinum toxin A "Botox Cosmetics"	Botulinum toxin A "Botox Cosmetics"	Croma-Pharma GmbH	marketed	Neurotoxin; acetylcholine release inhibitor	SNARE complex (synaptosome-associated protein); acetylcholine release machinery
botulinum type a	botulinum type a	Henry Ford Health System	marketed	Neurotoxin; botulinum toxin	SNARE proteins (synaptobrevin, SNAP-25, syntaxin); acetylcholine release machinery

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neurotoxin; neuromuscular blocking agent class)

Ivo Pitanguy Institute · 1 drug in this class
Lanzhou Institute of Biological Products Co., Ltd · 1 drug in this class
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust · 1 drug in this class
University of Utah · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Botulinum Toxin-A injection — Competitive Intelligence Brief. https://druglandscape.com/ci/botulinum-toxin-a-injection. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab